Phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by protein kinase N |
| |
Authors: | Hamaguchi T Ito M Feng J Seko T Koyama M Machida H Takase K Amano M Kaibuchi K Hartshorne D J Nakano T |
| |
Institution: | First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie, 514-8507, Japan. |
| |
Abstract: | CPI-17 is a phosphorylation-dependent inhibitory protein for smooth muscle myosin phosphate. Phosphorylation at Thr(38), in vitro, by protein kinase C or Rho-kinase enhances the inhibitory potency toward myosin phosphatase. Phosphorylation of CPI-17 by protein kinase N (PKN), a fatty acid- and Rho-activated serine/threonine kinase, and its effect on smooth muscle myosin phosphatase activity were investigated. CPI-17 was phosphorylated by GST-PKN-CAT, a constitutively active GST-fusion fragment of PKN, to 1.46 mol of P/mol of CPI-17, in vitro. The K(m) value of CPI-17 for PKN was 0.96 microM. Phosphorylation of PKN dramatically increased the inhibitory effect of CPI-17 on myosin phosphatase activity. The major and inhibitory phosphorylation site was identified as Thr(38) using a point mutant of CPI-17 and a phosphorylation-state specific antibody. Thus, CPI-17 is a substrate of PKN and might be involved in the Ca(2+) sensitization of smooth muscle contraction as a downstream effector of Rho and/or arachidonic acid. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|